FIELD: pharmacology.
SUBSTANCE: invention relates to a compound of formula
having a basic structure of 7 beta-hydroxycholesterol, where A is a group of -(R1)n, where R1 is an amino acid residue of glycine or alanine attached to its C-terminus, and n is 1 or 2. Moreover, R1 are the same or differentt and the N-terminus of the said amino acid is substituted with -C(O)-R2, where R2 is a benzyloxy group or a -(R1)n group, where R1 is an amino acid residue of glycine or alanine, n is 1 or 2, and the N-terminus of the said amino acid is substituted with benzyloxycarbonyl; or -C(O)-R6 group, where R6 is a five-member heterocycle comprising 2 oxygen heteroatoms unsubstituted or substituted with at least one unbranched or branched C1-C6alkyl; B is a -C(O)-R7 group, where R7 is C1-C6alkyl, unbranched or branched; or R7 is OR8, where R8 is C1-C6alkyl unbranched or branched. The invention also relates to individual compounds, a process for the preparation of a formula (I) compound, and a pharmaceutical composition having activity against transformed astrocyte cells.
EFFECT: new compounds of the formula are obtained that can be used to treat diseases associated with transformed astrocytes.
15 cl, 4 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION CONTAINING 7β-HYDROXYCHOLESTEROL AND A LIPID VEHICLE AND ITS USE IN THE TREATMENT OF NEOPLASTIC PATHOLOGIES | 2019 |
|
RU2803241C2 |
NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2018 |
|
RU2785126C2 |
NOVEL AMPHYL DERIVATIVES OF ALFA-C-PHENYL-N-TRET-BUTYLNITRONE | 2003 |
|
RU2364602C2 |
NEW SALICYLIC ACID DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALT, COMPOSITIONS AND METHOD FOR APPLICATION | 2013 |
|
RU2641903C2 |
PYRIMIDINE DERIVATIVES USED AS PROTEIN KINASE INHIBITORS | 2008 |
|
RU2478100C2 |
QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | 2015 |
|
RU2760686C2 |
COMPOSITIONS FOR TREATMENT OF NEURODEGERATIVE DISEASES | 2018 |
|
RU2792562C2 |
NEW INHIBITORS OF BACTERIAL GLUTAMINYL CYCLASES FOR USE IN THE TREATMENT OF PERIODONTAL AND RELATED DISEASES | 2019 |
|
RU2805298C2 |
COMPOUNDS FOR TREATMENT OF CANCER | 2015 |
|
RU2805949C2 |
METHODS FOR TREATMENT OF BLADDER CANCER | 2019 |
|
RU2795220C2 |
Authors
Dates
2017-08-10—Published
2013-05-07—Filed